Prevalence of metabolic syndrome in people living with HIV and its multi-organ damage: a prospective cohort study.

ABSTRACT:

Introduction

With the global scale-up of antiretroviral therapy (ART) and improved life expectancy, people living with HIV (PLWH) increasingly face non-infectious comorbidities, and metabolic syndrome (MetS) is one of the most prevalent. MetS is associated with unfavorable health outcomes, including cardiovascular disease, chronic kidney disease, and metabolic dysfunction-associated fatty liver disease. However, data on the prevalence and risk factors of MetS among treatment-naïve PLWH in China are limited. The aim was to investigate the prevalence and risk factors of MetS and to understand its association with multi-organ damage.

Methods

Data on sociodemographic, physical, and clinical characteristics were collected from a completed multicenter, prospective cohort study in

SUBMITTER: Tang J 

PROVIDER: S-EPMC11905433 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature